Cercar
01/12/2024
Ciprofloxacin for the Treatment of Infections Caused by Carbapenemase-Producing Gram-Negative Bacteria
Rubinan, P, Viñado, B, Fernández-Hidalgo, N, Larrosa, N, Sempere, A, Campany, D, Rodríguez-Pardo, D, González-López, JJ, Nuvials, X, del Barrio-Tofiño, E, Escolà-Vergé, L, Los-Arcos, I. Ciprofloxacin for the Treatment of Infections Caused by Carbapenemase-Producing Gram-Negative Bacteria. Antibiotics-Basel. 2024; 13(12)DOI:10.3390/antibiotics13121138. PMID:39766528. IF:4.600(Q1/2D).
21/02/2026
Adequacy of the Type of Venous Catheter to the Drug Type and Duration of Treatment: A Cross-Sectional Study
Moreno-Rubio, E, Pérez-López, C, Carmezim, J, Blancas-Altabella, D, Simonetti, AF, Sanchez, SS, Rodríguez-Molinero, A. Adequacy of the Type of Venous Catheter to the Drug Type and Duration of Treatment: A Cross-Sectional Study. Nursing Reports. 2026; 16(2)DOI:10.3390/nursrep16020076. PMID:41745901. IF:(Q/D).
01/08/2024
Characterization of white matter hyperintensities in Down syndrome
Morcillo-Nieto, AO, Zsadanyi, SE, Arriola-Infante, JE, Carmona-Iragui, M, Montal, V, Pegueroles, J, Aranha, MR, Vaque-Alcazar, L, Padilla, C, Benejam, B, Videla, L, Barroeta, I, Fernandez, S, Altuna, M, Gimenez, S, Gonzalez-Ortiz, S, Bargallo, N, Ribas, L, Arranz, J, Torres, S, Iulita, MF, Belbin, O, Camacho, V, Alcolea, D, Lleo, A, Fortea, J, Bejanin, A. Characterization of white matter hyperintensities in Down syndrome. ALZHEIMERS & DEMENTIA. 2024; 20(9)DOI:10.1002/alz.14146. PMID:39087352. IF:11.100(Q1/1D).
26/03/2024
Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP
Ospina, AV, Nadal, SB, de la Cruz, JLCC, Larriba, JLG, Vidueira, IM, Sureda, BM, Nadal, E, Trancho, FH, Kindelan, AA, Morillo, E, Caro, RB, Barrera, JB, de Juan, VC, Rubio, JC, de Castro, J, Ramos, AC, Dols, MC, Gomez, M, Almanzar, S, Campelo, RG, Molla, AI, Sarceda, JRJ, Maestre, UJ, Castro, RL, Majem, M, Martinez-Marti, A, Tellez, EM, Lorente, DS, Provencio, M. Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP. Clinical & Translational Oncology. 2024; DOI:10.1007/s12094-024-03382-y. PMID:38530556. IF:2.500(Q3/6D).